NCT05676814

Brief Summary

The purpose of this randomized, triple-blinded, prospective, feasibility study is to compare postoperative analgesia provided by Pecto-intercostal Fascial Block (PIFB) when performed with local anesthetic solution with or without perineural adjuvants in patients following cardiac surgery involving sternotomy. The study team hypothesizes that the patients receiving PIFB with bupivacaine with epinephrine, clonidine, and dexamethasone will have lower dynamic pain over the first 36 hours compared to those receiving PIFB with just bupivacaine and epinephrine.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
31

participants targeted

Target at below P25 for phase_4

Timeline
Completed

Started Mar 2023

Shorter than P25 for phase_4

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 22, 2022

Completed
18 days until next milestone

First Posted

Study publicly available on registry

January 9, 2023

Completed
2 months until next milestone

Study Start

First participant enrolled

March 24, 2023

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 23, 2023

Completed
1 day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 24, 2023

Completed
12 months until next milestone

Results Posted

Study results publicly available

June 11, 2024

Completed
Last Updated

June 11, 2024

Status Verified

April 1, 2024

Enrollment Period

3 months

First QC Date

December 22, 2022

Results QC Date

January 11, 2024

Last Update Submit

May 13, 2024

Conditions

Keywords

Pecto-intercostal Fascial BlockPostoperativePainCardiac Surgery

Outcome Measures

Primary Outcomes (5)

  • Area Under the Curve (AUC) Pain Score - Based on Patient-reported Dynamic Numerical Rating Scale (NRS) Pain Scores

    Based on patient-reported dynamic Numerical Rating Scale (NRS) pain scores with incentive spirometer (IS) use in subjects that are extubated. Pain scores range from 0 to 10 with higher scores denoting more pain. 0 to 6 hrs after placement.

    0 to 6 hours after block placement

  • Area Under the Curve (AUC) Pain Score - Based on Patient-reported Dynamic Numerical Rating Scale (NRS) Pain Scores

    Based on patient-reported dynamic NRS pain scores with incentive spirometer (IS) use in subjects that are extubated. Pain scores range from 0 to 10 with higher scores denoting more pain.

    12 hours after block placement

  • Area Under the Curve (AUC) Pain Score - Based on Patient-reported Dynamic Numerical Rating Scale (NRS) Pain Scores

    Based on patient-reported dynamic NRS pain scores with incentive spirometer (IS) use in subjects that are extubated. Pain scores range from 0 to 10 with higher scores denoting more pain.

    18 hours after block placement

  • Area Under the Curve (AUC) Pain Score - Based on Patient-reported Dynamic Numerical Rating Scale (NRS) Pain Scores

    Based on patient-reported dynamic NRS pain scores with incentive spirometer (IS) use in subjects that are extubated. Pain scores range from 0 to 10 with higher scores denoting more pain.

    24 hours after block placement

  • Area Under the Curve (AUC) Pain Score - Based on Patient-reported Dynamic Numerical Rating Scale (NRS) Pain Scores

    Based on patient-reported dynamic NRS pain scores with incentive spirometer (IS) use in subjects that are extubated. Pain scores range from 0 to 10 with higher scores denoting more pain.

    36 hours after block placement

Secondary Outcomes (11)

  • Patient-reported Numerical Rating Scale (NRS) Pain Scores at Rest

    6 hours after block placement

  • Patient-reported Numerical Rating Scale (NRS) Pain Scores at Rest

    6, 12, 18, 24 hours after block placement

  • Average Cumulative Opioid Consumption

    36 hours after block placement

  • Average Time to First Opioid Administration

    Up to 36 hours after block placement

  • Average Time to Extubation

    Up to 36 hours after block placement

  • +6 more secondary outcomes

Study Arms (2)

Pecto-intercostal Fascial Block (PIFB)

ACTIVE COMPARATOR

Subjects in this arm receive standard of care PIFB after surgery

Drug: Pecto-intercostal Fascial Block (PIFB)

PIFB with adjuvants

EXPERIMENTAL

Subjects in this arm receive standard of care PIFB with additional medications after surgery

Drug: PIFB with adjuvants

Interventions

PIFB done with bupivacaine and epinephrine

Pecto-intercostal Fascial Block (PIFB)

PIFB with bupivacaine, epinephrine, clonidine, and dexamethasone

PIFB with adjuvants

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults between undergoing cardiac surgery involving sternotomy

You may not qualify if:

  • Patients with any contraindications to regional anesthesia, such as history of allergy to amide local anesthetics or any of the perineural adjuvants
  • existing neurologic deficit in the chest wall;
  • remaining intubated at the six hour point after block placement
  • weight under 50kg
  • undergoing emergency surgical procedures or urgent return to the operating room
  • active endocarditis or mediastinitis
  • moderate to severe right ventricular function before or after cardiopulmonary bypass
  • reliance on mechanical circulatory support devices, such as intra-aortic balloon pump or Impella
  • reliance on extracorporeal membrane oxygenation
  • localized or systemic infection
  • chronic use of high dose opioid analgesics (defined as daily use greater than 30 oral morphine milligram equivalents (OMME) for over one month prior to surgery)
  • those who are pregnant

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Wake Forest Health Sciences

Winston-Salem, North Carolina, 27157, United States

Location

MeSH Terms

Conditions

AgnosiaPain

Condition Hierarchy (Ancestors)

Perceptual DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Results Point of Contact

Title
Scott Coleman, DO
Organization
Wake Forest University Health Sciences

Study Officials

  • Scott Coleman, DO

    Wake Forest University Health Sciences

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
Patients will be blinded to their treatment arm assignment, as will all research personnel who be responsible for collection of outcome data, as well as the surgeons performing the procedure, and critical care staff caring for the patients in the postoperative period. The anesthesiologist who will be performing the Pecto-intercostal Fascial Block (PIFB) will open the envelope informing them of the arm assignment; they will be the only care providers unblinded.
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 22, 2022

First Posted

January 9, 2023

Study Start

March 24, 2023

Primary Completion

June 23, 2023

Study Completion

June 24, 2023

Last Updated

June 11, 2024

Results First Posted

June 11, 2024

Record last verified: 2024-04

Data Sharing

IPD Sharing
Will not share

Locations